What the study was about
Researchers investigated whether Ipamorelin— a synthetic peptide that stimulates the body’s own growth hormone (GH) release — could promote bone growth in adult rats. This is important because growth hormone plays a key role in bone development and health.
How the study was done
- The experiment used adult female rats.
- Researchers measured how fast the rats’ long bones were growing and also tracked changes in body weight.
Key Results
Dose‑dependent growth
- Rats treated with higher doses of ipamorelin had greater longitudinal bone growth.
- Bone growth increased from about 42 µm/day in untreated rats to up to 52 µm/day in treated animals.
Increased body weight
- Rats receiving ipamorelin tended to gain more body weight than those that did not receive it.
What Didn’t Change
- The total amount of growth hormone stored in the pituitary gland did not change.
- The number of certain bone‑remodeling cells (osteoclasts) didn’t change significantly.
- Markers in the blood that usually show bone formation or breakdown stayed about the same.
Main Takeaway
The study found that ipamorelin stimulates bone length growth in rats in a dose‑dependent manner — meaning the more peptide given, the more bone growth was observed. This suggests that ipamorelin, by increasing the release of growth hormone, may help promote skeletal growth and potentially support bone health.
Source for Reference
- Johansen, P.B. et al. “Ipamorelin, a new growth‑hormone‑releasing peptide, induces longitudinal bone growth in rats” — found in Growth Hormone & IGF Research and indexed on PubMed.